Strides Pharma Science Ltd financial statements
Strides Pharma Science Ltd's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2026
| Revenue | INR 48.59B | EODHD |
| Net income | INR 5.56B | EODHD |
| Cash and equivalents | INR 2.13B | EODHD |
| Total debt | INR 17.58B | EODHD |
Strides Pharma Science Ltd financials on 6ix · Strides Pharma Science Ltd on 6ix